Health Tech Market Forecast for 2030: Size, Drivers, and Competitive Outlook

2030 Projections: Health Tech’s Next $800 Billion Frontier

Analysts expect global health tech to crest past the $800 billion mark by 2030, powered by persistent demand for virtual care, digitized clinical workflows, and consumer-grade devices. The overall digital health market is projected to reach roughly $809.2 billion by 2030, according to Grand View Research, with telehealth continuing to capture a major share of incremental spend. Big platform players including Apple, Alphabet, and Amazon are deepening their healthcare footprints, betting on device-led engagement, data interoperability, and low-friction access to care.

Telehealth remains the headline growth engine. The global telehealth market is forecast to reach approximately $455 billion by 2030, per Grand View Research, as hybrid and remote-first models move from pandemic-era stopgaps to standard offerings. Meanwhile, AI-enabled clinical tools are approaching commercial scale; the AI in healthcare segment is set to surpass $100 billion before decade’s end, according to MarketsandMarkets, underpinning triage, imaging, and decision support across provider networks.

Revenue Mix and Segment Outlook to 2030

The 2030 revenue picture is increasingly multi-modal. Telehealth platforms—anchored by virtual urgent care and behavioral health—are expected to benefit from an expanding employer and payer footprint, with category leaders like Teladoc Health prioritizing longitudinal care, chronic disease management, and integration with on-prem clinical pathways. On the enterprise side, electronic health record ecosystems from Epic Systems and Oracle Health are layering AI co-pilots and ambient documentation to improve throughput and revenue cycle performance.

Hardware-led monitoring will remain another pillar of growth. Connected devices from Medtronic, Abbott, and Philips are proliferating in cardiology, diabetes, and post-acute care. Consumer-grade wearables—enabled by platforms from Apple and Alphabet—increasingly feed clinical-grade insights, making device-data pipelines central to patient stratification and risk adjustment in value-based contracts.

Regulation, Reimbursement, and Data Infrastructure

Policy will shape margins as much as technology. U.S. telehealth flexibilities have continued to evolve, and guidance points to durable reimbursement pathways for remote care and remote physiologic monitoring, as summarized by the federal telehealth clearinghouse at HHS. Large payers such as UnitedHealth Group are expanding virtual-first plans and data-sharing incentives as they lay the groundwork for outcomes-based payments tied to digital engagement.

Data integration is a competitive differentiator heading into 2030. Provider platforms from Epic Systems and Oracle Health are moving toward tighter API access, clinical decision support, and ambient documentation, which should shave administrative costs while improving clinical quality. For consumer ecosystems, Apple and Alphabet continue to invest in privacy-preserving analytics that make longitudinal data usable across care settings without compromising compliance.

Competitive Dynamics and M&A: Platforms vs. Point Solutions

The investment climate remains active. Private equity dry powder and strategic appetite point to ongoing consolidation in digital health and medtech, with dealmakers prioritizing durable unit economics and payer alignment, as detailed in Bain’s Global Healthcare Private Equity and M&A Report. Platform players such as Amazon are pursuing end-to-end journeys—from discovery to e-pharmacy fulfillment—while incumbents like Philips and Medtronic stitch together home-to-hospital telemetry.

Early-stage innovation remains vibrant. Startups including Butterfly Network (handheld ultrasound) and Tempus (AI-enabled precision medicine) are scaling evidence and distribution, positioning themselves as acquisition targets or future category leaders. This builds on broader Health Tech trends such as ambient clinical AI, automation in prior authorization, and distributed diagnostics that reduce time-to-treatment and readmissions.

Regional Outlook and Risks into 2030

North America will remain the largest revenue pool, but Asia-Pacific is set to outpace growth thanks to rising consumer spend and hospital digitization. Europe is poised for steady expansion, with regional interoperability mandates and cross-border care modernization acting as structural tailwinds. Across markets, virtual behavioral health and remote cardio-metabolic care are expected to capture outsized wallet share through 2030.

Key risks include reimbursement retrenchment, data fragmentation, security incidents, and uneven clinical validation. The winners will be those that can demonstrate cost savings and quality improvements at scale, backed by peer-reviewed outcomes and payer contracts. For more on related Health Tech developments, watch the interplay between enterprise platforms and device ecosystems as health systems standardize on fewer vendors with deeper integrations.

What to Watch: Execution Benchmarks for the Next Five Years

Heading into the home stretch of the decade, expect health systems to prioritize vendor consolidation, AI-enabled throughput, and longitudinal digital engagement. Look for proof points: reductions in no-show rates from virtual workflows, improved readmission metrics from remote monitoring, and more efficient documentation through ambient AI co-pilots integrated by Epic Systems and Oracle Health.

On the consumer side, device platforms from Apple and Alphabet will increasingly anchor coaching, adherence, and early detection—creating new collaboration models with care delivery networks and payers like UnitedHealth Group. The strategic question through 2030 is not whether health tech grows, but who captures the margin: EHR platforms, virtual care providers, device makers, or integrated consumer ecosystems backed by retail-scale logistics from Amazon.